MERIT MEDICAL SYSTEMS INC
In the published model solve dated 2026-Q2, anchored at $87.19, MERIT MEDICAL SYSTEMS INC (MMSI) is priced for +20.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
• Merit Medical makes disposable devices for interventional and diagnostic procedures across cardiology, radiology, oncology, and endoscopy, a steady, procedure-driven business that grew first-quarter sales 7.5% to $381.9 million and runs a gross margin near 48%. [Source: Merit Medical Q1 2026 results, 2026] • The single number that defines the bet is growth: the price embeds roughly 15% annual operating growth, while recent organic, constant-currency growth ran about 3.7%, so the gap between pr
Is MMSI overvalued? See what's priced in →
388 institutional managers reported holding MMSI in 13F filings for the quarter ended 2026-03-31. 61 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 3.0M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MMSI's share count grew 6.2% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MMSI over the trailing three years. Absence is a fact about the company, not a signal. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MMSI's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-29 | -9.5% | -6.2% |
| 2023-10-27 | +7.8% | +10.1% |
| 2024-02-29 | -5.4% | +1.1% |
| 2024-05-01 | +2.2% | +11.9% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MMSI's latest 8-K filings: 2026-07-30 (items 2.02, 7.01, 9.01); 2026-05-19 (items 5.02, 5.03, 5.07, 7.01, 9.01); 2026-04-30 (items 2.02, 7.01, 9.01); 2026-04-13 (items 7.01, 9.01); 2026-04-01 (items 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.